Biofrontera Inc. short interest in 2022
In 2022, Biofrontera Inc.'s disclosed short interest ran from 11.49% of shares outstanding on 14 Jan 2022 to 1.75% on 30 Dec 2022, a change of -9.74 percentage points. The year's high was 11.49% on 14 Jan 2022 and its low 0.84% on 15 Sep 2022, averaging 3.98% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.00 days on 30 Nov 2022. Full history: Biofrontera Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 11.49% (14 Jan 2022)
- End of year
- 1.75% (30 Dec 2022)
- Change
- -9.74 pp
- High
- 11.49% (14 Jan 2022)
- Low
- 0.84% (15 Sep 2022)
- Average
- 3.98%
- Highest days to cover
- 11.00 (30 Nov 2022)
- SEC filings marked
- 12
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 11.49% | 1.00 | results (8-K) |
| 31 Jan 2022 | 7.08% | 1.00 | |
| 15 Feb 2022 | 6.99% | 1.00 | |
| 28 Feb 2022 | 7.55% | 1.42 | |
| 15 Mar 2022 | 7.09% | 1.37 | |
| 31 Mar 2022 | 7.35% | 1.00 | |
| 14 Apr 2022 | 5.81% | 1.00 | results (8-K), results (8-K), 10-K filed |
| 29 Apr 2022 | 5.93% | 1.14 | |
| 13 May 2022 | 3.33% | 1.69 | 10-Q filed, results (8-K) |
| 31 May 2022 | 3.12% | 2.65 | |
| 15 Jun 2022 | 4.48% | 3.27 | |
| 30 Jun 2022 | 3.64% | 1.88 | |
| 29 Jul 2022 | 1.61% | 1.00 | results (8-K) |
| 15 Aug 2022 | 1.44% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 1.19% | 1.00 | |
| 15 Sep 2022 | 0.84% | 1.00 | |
| 30 Sep 2022 | 1.14% | 1.00 | |
| 14 Oct 2022 | 1.83% | 2.33 | results (8-K) |
| 31 Oct 2022 | 2.29% | 5.25 | |
| 15 Nov 2022 | 2.16% | 5.78 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 1.99% | 11.00 | |
| 15 Dec 2022 | 1.49% | 5.87 | |
| 30 Dec 2022 | 1.75% | 2.94 |
See also: Biofrontera Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.